AI-Powered Seizure Detection: PetPace Launches Beta Program for Canine Epilepsy Monitoring
Mana Commerce spotlights PetPace’s groundbreaking Epilepsy Insights module, advancing real-time seizure tracking for dogs.
Aug 15, 2025 · 1 Minute Read 
Mana Commerce, a division of Mana Common, continues to champion innovation in pet health technology—this time with a leap forward in canine epilepsy care. PetPace, the leader in AI-powered smart collars, has introduced its Epilepsy Insights module, now available for beta testing. This first-of-its-kind solution leverages award-winning AI and machine learning to detect seizures automatically, track episodes over time, and deliver actionable health data for veterinarians and pet owners.
Epilepsy affects as many as 1 in 20 dogs, with causes ranging from inherited disorders to brain trauma and disease. PetPace’s new module aims to replace guesswork with precise, AI-driven insights, alerting pet parents within an hour of a seizure—whether they’re at home or away. Through continuous monitoring and visual trend reports, the technology supports early intervention, effective treatment planning, and 24/7 peace of mind.
Participants in the limited beta program will receive the module as a free add-on when officially launched, contributing valuable feedback to shape the future of canine epilepsy management. By supporting advancements like Epilepsy Insights, Mana Commerce reinforces Miami’s role as a center for next-generation wellness solutions.
For more about PetPace and to apply for the beta program, visit petpace.com.
Apply for PetPace Epilepsy Beta
